Overview
Friedreich ataxia (FA) is the most common autosomal recessive cerebellar ataxia, characterized by progressive loss of coordination, cardiomyopathy, and diabetes mellitus1Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice.Open reference. The disease is caused by a pathogenic GAA repeat expansion in the first intron of the FXN gene, which encodes the mitochondrial protein frataxin2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference. Reduced frataxin expression leads to impaired iron-sulfur cluster assembly, mitochondrial dysfunction, and progressive degeneration of the dorsal root ganglia, cerebellum, and heart3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference.
Friedreich ataxia typically presents in childhood, with onset between 5-15 years of age, and progresses to severe disability by early adulthood4Ethics of comanagement.Open reference. The disease affects approximately 1 in 40,000-50,000 individuals in Caucasian populations, with lower prevalence in other ethnic groups5Intraoperative enteroscopy.Open reference. Despite being a single-gene disorder, FA exhibits remarkable phenotypic variability, with some patients showing milder disease courses and others experiencing rapid progression6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference.
Genetics
Gene and Mutation
The FXN gene is located on chromosome 9q13-21.1 and encodes frataxin, a 210-amino acid mitochondrial protein essential for iron homeostasis
The size of the GAA repeat correlates with disease severity:
-
Normal: 5-33 repeats
-
Intermediate (carrier): 34-66 repeats
-
Pathological: 66-1700 repeats8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference
Larger repeat expansions are associated with:
-
Earlier age of onset
-
More severe neurological phenotype9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference
-
Earlier onset of cardiomyopathy10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference
-
Faster disease progression2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference0
Frataxin Function
Frataxin is a mitochondrial protein that plays critical roles in:
-
Iron-sulfur cluster (Fe-S) assembly: Frataxin is an essential cofactor for the Fe-S cluster scaffold protein ISCU, facilitating the transfer of iron and sulfur for cluster formation2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference1
-
Iron storage and regulation: Frataxin helps maintain mitochondrial iron homeostasis by regulating iron import through the mitochondrial iron transporter MITOCHONDRIAL IRON IMPORT PROTEIN (MITO7)2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference2
-
Electron transport chain function: Normal frataxin levels are required for the assembly and function of mitochondrial complexes I, II, and III, as well as aconitase
-
Antioxidant defense: Frataxin deficiency leads to increased oxidative stress due to impaired Fe-S cluster assembly and increased free iron2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference3
Pathophysiology
Mitochondrial Dysfunction
Frataxin deficiency leads to multiple mitochondrial impairments:
-
Reduced Fe-S cluster synthesis: Impaired assembly of Fe-S clusters affects the function of multiple enzymes including aconitase, complexes I-III, and electron transfer flavoprotein2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference4
-
Iron accumulation: Mitochondrial iron overload with normal cytosolic iron levels leads to oxidative damage through Fenton chemistry2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference5
-
Energy failure: Reduced ATP production due to impaired oxidative phosphorylation
-
Increased reactive oxygen species (ROS): Elevated ROS production causing lipid peroxidation, protein oxidation, and DNA damage2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference6
Tissue-Specific Vulnerability
Different tissues show varying susceptibility to frataxin deficiency:
-
Dorsal root ganglia (DRG): Most severely affected, with neurons loss, demyelination, and gliosis2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference7
-
Cardiac muscle: Hypertrophic cardiomyopathy with fibrosis, leading to heart failure2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference8
-
Cerebellar Purkinje cells: Progressive degeneration leading to ataxia2Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference9
-
Pancreatic β-cells: Impaired insulin secretion leading to diabetes mellitus3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference0
-
Skeletal muscle: Variable involvement with reduced exercise tolerance3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference1
Molecular Cascades
The downstream consequences of frataxin deficiency include:
-
Transcriptional dysregulation: Altered expression of genes involved in mitochondrial function, oxidative stress response, and neurons survival3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference2
-
Proteostasis disruption: Impaired mitochondrial protein quality control and accumulation of damaged proteins3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference3
-
Calcium dysregulation: Altered mitochondrial calcium handling leading to cellular stress3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference4
-
Apoptosis: Activation of intrinsic apoptotic pathways in affected neurons and cardiomyocytes3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference5
Clinical Features
Neurological Manifestations
Ataxia
The hallmark of Friedreich ataxia is progressive cerebellar ataxia, characterized by3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference6:
-
Gait instability: Broad-based, unsteady walking that worsens over time
-
Limb incoordination: Dysmetria, dysdiadochokinesia, and impaired finger-to-nose testing
-
Speech dysfunction: Dysarthria with scanning or staccato quality
-
Loss of fine motor control: Difficulty with writing, buttoning, and eating
The ataxia typically begins in the legs and progresses proximally, with upper limb involvement occurring within 5-10 years of disease onset3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference7.
Sensory Deficits
-
Loss of proprioception: Impaired position sense leading to sensory ataxia
-
Reduced vibration sense: Tested at the ankles, typically absent by adolescence3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference8
-
Sensory neuropathy: Small fiber involvement with reduced pain and temperature sensation3The pathogenesis of Friedreich ataxia and the structure and function of frataxin.Open reference9
Motor Features
-
Muscle weakness: Proximal weakness developing in the second decade
-
Spasticity: Upper motor neuron signs in some patients4Ethics of comanagement.Open reference0
-
Reflex loss: Areflexia, particularly in the lower extremities4Ethics of comanagement.Open reference1
Non-Ataxia Features
-
Optic atrophy: Visual impairment due to optic nerve degeneration in 30% of patients4Ethics of comanagement.Open reference2
-
Hearing loss: Sensorineural hearing loss in approximately 10%4Ethics of comanagement.Open reference3
-
Cognitive impairment: Learning difficulties and reduced IQ in some patients4Ethics of comanagement.Open reference4
Cardiac Involvement
Cardiomyopathy is present in over 95% of patients and is the leading cause of mortality4Ethics of comanagement.Open reference5:
-
Hypertrophic cardiomyopathy: Concentric hypertrophy of the left ventricle4Ethics of comanagement.Open reference6
-
Diastolic dysfunction: Impaired ventricular filling leading to heart failure4Ethics of comanagement.Open reference7
-
Arrhythmias: Atrial fibrillation, ventricular tachycardia4Ethics of comanagement.Open reference8
-
Heart failure: Progressive decline in cardiac function, typically in the third decade4Ethics of comanagement.Open reference9
Endocrine Manifestations
-
Diabetes mellitus: Present in approximately 30% of patients5Intraoperative enteroscopy.Open reference0
-
Glucose intolerance: Early evidence of pancreatic dysfunction5Intraoperative enteroscopy.Open reference1
-
Impaired insulin secretion: Reduced β-cell function due to mitochondrial dysfunction5Intraoperative enteroscopy.Open reference2
Musculoskeletal Complications
-
Scoliosis: Kyphoscoliosis in 60-80% of patients5Intraoperative enteroscopy.Open reference3
-
Pes cavus: High arched feet requiring orthopedic intervention5Intraoperative enteroscopy.Open reference4
-
Contractures: Joint contractures due to immobility5Intraoperative enteroscopy.Open reference5
Disease Course
The typical disease progression includes:
-
Age 5-15: Onset of ataxia, loss of reflexes, sensory deficits
-
Age 10-20: Development of cardiomyopathy, diabetes, musculoskeletal complications
-
Age 20-30: Severe disability, wheelchair dependence, cardiac complications
-
Median survival: 35-40 years from disease onset
Diagnosis
Clinical Diagnostic Criteria
The classic diagnostic criteria include:
-
Progressive ataxia starting before age 255Intraoperative enteroscopy.Open reference6
-
Loss of lower limb reflexes
-
Sensory loss with impaired vibration sense
-
Evidence of cardiomyopathy on EKG or echocardiogram
-
Family history consistent with autosomal recessive inheritance
Genetic Testing
GAA repeat testing: PCR-based detection of expanded GAA repeats in FXN intron 1
-
Sensitivity: 95% for homozygous expansions
-
Specificity: >99% with proper controls
FXN sequencing: For suspected compound heterozygotes or atypical cases5Intraoperative enteroscopy.Open reference7
-
Identifies point mutations, small insertions/deletions
-
Important for genetic counseling
Biomarkers
-
Frataxin levels: Reduced in peripheral blood mononuclear cells (PBMCs)5Intraoperative enteroscopy.Open reference8
-
Iron metabolism markers: Elevated ferritin, decreased transferrin saturation5Intraoperative enteroscopy.Open reference9
-
Oxidative stress markers: Increased 8-OHdG, lipid peroxidation products
-
Cardiac biomarkers: Elevated NT-proBNP, troponin levels6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference0
Neuroimaging
-
MRI brain: Atrophy of the cerebellar vermis and cervical spinal cord6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference1
-
MR spectroscopy: Reduced N-acetylaspartate in the cerebellum
-
Cardiac MRI: Late gadolinium enhancement indicating fibrosis6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference2
Management
Disease-Modifying Therapies
Frataxin-Targeting Approaches
-
Omaveloxolone (RTA 408): Nrf2 activator shown to improve neurological function in the MOXIe trial6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference3
-
Idebenone: Antioxidant compound with mixed results in clinical trials6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference4
-
Interferon-γ: Shown to increase frataxin expression in preclinical studies
-
Gene therapy: AAV-based frataxin delivery in clinical development6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference5
Experimental Approaches
-
Iron chelation: Deferiprone to reduce mitochondrial iron overload6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference6
-
Coenzyme Q10 and vitamin E: Mitochondrial support therapy6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference7
-
Phosphodiesterase inhibitors: Improve mitochondrial function6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference8
Symptomatic Management
Ataxia
-
Physical therapy: Gait training, balance exercises
-
Occupational therapy: Adaptive devices for daily activities6Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.Open reference9
-
Speech therapy: For dysarthria management
-
Assistive devices: Walking aids, wheelchairs as disease progresses7Congenital localized scleroderma.Open reference0
Cardiac Management
-
Beta-blockers: For hypertrophic cardiomyopathy and arrhythmias7Congenital localized scleroderma.Open reference1
-
ACE inhibitors/ARBs: For heart failure prevention7Congenital localized scleroderma.Open reference2
-
Antiarrhythmic drugs: For rhythm management7Congenital localized scleroderma.Open reference3
-
Pacemaker/defibrillator: For advanced conduction disease7Congenital localized scleroderma.Open reference4
-
Cardiac transplantation: For end-stage heart failure7Congenital localized scleroderma.Open reference5
Diabetes Management
-
Insulin therapy: For frank diabetes mellitus7Congenital localized scleroderma.Open reference6
-
Oral hypoglycemics: Metformin may be beneficial due to mitochondrial effects7Congenital localized scleroderma.Open reference7
-
Dietary management: Carbohydrate counting and glycemic control7Congenital localized scleroderma.Open reference8
Musculoskeletal Care
-
Orthopedic surgery: For severe scoliosis or contractures
-
Physical therapy: To maintain joint mobility7Congenital localized scleroderma.Open reference9
-
Orthotics: Ankle-foot orthoses for pes cavus8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference0
Emerging Therapies
-
Synthetic frataxin analogs: Small molecules that restore frataxin function
-
RNA therapeutics: Antisense oligonucleotides to increase frataxin expression8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference1
-
Stem cell therapy: Mitochondrial replacement approaches8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference2
-
Mitochondrial antioxidants: New generations of ROS scavengers8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference3
Animal Models
Mouse Models
-
Fxn conditional knockout: Tissue-specific deletion allowing study of frataxin function8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference4
-
GAA repeat knock-in: Mimics human disease with progressive phenotype8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference5
-
Humanized mouse models: Express human FXN with pathological repeats8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference6
Phenotypic Features
Mouse models recapitulate key features:
-
Cardiac hypertrophy and dysfunction
-
Progressive gait ataxia8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference7
-
Iron accumulation in mitochondria8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference8
-
Reduced lifespan8Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.Open reference9
Therapeutic Testing
Animal models have been used to test:
-
Idebenone: Showed efficacy in cardiomyopathy
-
Omaveloxolone: Demonstrated Nrf2 pathway activation9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference0
-
Gene therapy: AAV delivery successfully increased frataxin levels9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference1
Research Directions
Current therapeutic development focuses on:
-
Frataxin restoration: Gene therapy, RNA therapeutics, small molecule stabilizers9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference2
-
Mitochondrial function: CoQ10 analogs, electron transfer enhancers9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference3
-
Oxidative stress reduction: Nrf2 activators, antioxidants
-
Iron homeostasis: Chelators, iron regulatory proteins9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference4
-
Symptom management: Improved cardiac monitoring, diabetes prevention
Clinical trials are ongoing for multiple candidates, with the goal of developing therapies that can slow or halt disease progression9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference5.
Prognosis
Life Expectancy
-
Median survival: 35-40 years from onset
-
Causes of death: Cardiomyopathy (60%), respiratory complications (20%), other (20%)9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference6
Prognostic Factors
Favorable prognostic factors:
-
Smaller GAA repeat size: Less severe disease9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference7
-
Late onset: After age 20 typically indicates milder phenotype9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference8
-
Preserved reflexes: Intact lower limb reflexes associated with slower progression
Poor prognostic factors:
-
Early onset: Before age 10 associated with rapid progression9Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Open reference9
-
Large GAA repeats: >500 repeats on both alleles10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference0
-
Cardiac involvement: Early severe cardiomyopathy10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference1
-
Diabetes mellitus: Presence of diabetes worsens prognosis10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference2
Quality of Life
-
Most patients require wheelchair assistance by their early twenties10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference3
-
Cognitive function is typically preserved, allowing for educational and professional pursuits10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference4
-
Psychological support is important given the chronic progressive nature10Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Open reference5
See Also
External Links
Pathway Diagram
graph TD
A["Friedreich's Ataxia"] --> B["Pathophysiology"]
B --> C["Molecular Mechanisms"]
B --> D["Cellular Changes"]
C --> E["Genetic Risk Factors"]
D --> F["Clinical Manifestations"]
C -->|"involves"| G0["STIP1"]
C -->|"involves"| G1["LGALS3"]
C -->|"involves"| G2["HSPA8"]References
- Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice.
- Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
- The pathogenesis of Friedreich ataxia and the structure and function of frataxin.
- Ethics of comanagement.
- Intraoperative enteroscopy.
- Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
- Congenital localized scleroderma.
- Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
- Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.
- Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.
- Sarcoidosis.
- Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
- Eyelid sparganosis.
- Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
- Biochemical Reconstitution and Spectroscopic Analysis of Iron-Sulfur Proteins.
- Pneumococcal mastoiditis in children.
- [Transplant of livers from living relatives: selection of recipients and donors].
- Role of extracellular adenosine in acute lung injury.
- The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
- Recurrent R-spondin fusions in colon cancer.
- An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells.
- Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
- Circulating free nitrotyrosine and cognitive decline.
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
- Translational imaging studies of cortical spreading depression in experimental models for migraine aura.
- The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
- Interactions between CLIP-170, tubulin, and microtubules: implications for the mechanism of Clip-170 plus-end tracking behavior.
- Orbital tuberculosis.
- Congenital ocular defects associated with an abnormality of the human chromosome 1: trisomy 1q32-qter.
- Discovery of a novel noniminosugar acid α glucosidase chaperone series.
- Genes involved in hereditary ataxias.
- Clinical and genetic study of Friedreich ataxia in an Australian population.
- Diagnostic pathology for the cancer patient.
- An analysis of correlation between the unusual location of the jugular bulb and audiovestibular symptoms.
- Clinical features of Friedreich ataxia.
- Cardiovascular risk.
- Marked variation in the cardiomyopathy associated with Friedreich's ataxia.
- System for deep venous thrombosis detection using objective compression measures.
- Breastfeeding and maternal and infant health outcomes in developed countries.
- The restrictive cardiomyopathies.
- Familial focal congenital hyperinsulinism.
- Interferon-gamma expression is an independent prognostic factor in ovarian cancer.
- Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training?
- The hemodynamically unstable patient in the intensive care unit: hemodynamic vs. transesophageal echocardiographic monitoring.
- Continuous ambulatory peritoneal dialysis: three years' experience.
- Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
- Stimulation of neutrophil apoptosis by immobilized IgA.
- Old meets new: the interaction between innate and adaptive immunity.
- Pandemic human viruses cause decline of endangered great apes.
- Two hybridization events define the population structure of Trypanosoma cruzi.
- Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.
- Posterior spinal artery infarct.
- Common variations in 4p locus are related to male completed suicide.
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
- FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.
- Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
- "N-of-1"-Study: A concept of acute and chronic stress research using the example of ballroom dancing.
- Myocarditis.
- Implementation of Digital Pathology Offers Clinical and Operational Increase in Efficiency and Cost Savings.
- Axonal pathology in traumatic brain injury.
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
- Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
- Deciphering the Nucleotide and RNA Binding Selectivity of the Mayaro Virus Macro Domain.
- The nuts and bolts of low-level laser (light) therapy.
- Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
- Type 2 diabetes mellitus--an autoimmune disease?
- Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
- Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.
- Evaluation of Acute Exogenous Hypoxia Impact on the Fraction of Exhaled Nitric Oxide in Healthy Males.
- Topography of geographic atrophy in age-related macular degeneration.
- Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
- Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
- Validation of a digital pathology system including remote review during the COVID-19 pandemic.
- Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis.
- Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.
- A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.
- Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia.
- Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
- Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.
- Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.
- Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
- Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis.
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
- Lignans: Quantitative Analysis of the Research Literature.
- Immunometabolic interference between cancer and COVID-19.
- Towards an understanding of cognitive function in Friedreich ataxia.
- Accuracy of clinical diagnostic criteria for Friedreich's ataxia.
- Fracture of the cervical spine in ankylosing spondylitis.
- Friedreich's ataxia. Revision of the phenotype according to molecular genetics.
- Frataxin fracas.
- Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
- [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)].
- Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms.
- Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement.
- Isolation of Genetically Tractable Most-Wanted Bacteria by Metaparental Mating.
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.